Navigation Links
Painkillers Linked to Still More Problems

Two recent studies have offered still more evidence of the dangers linked with certain painkillers including kidney problems// in addition to the heart concerns that was already raised with the drug marketed as Vioxx.

One report from Brigham and Women's Hospital, and Harvard Medical School, Boston, said that an analysis of 114 studies that involved over 116,000 people showed that rofecoxib commonly known as Vioxx "was associated with increased renal and (heart) arrhythmia risks."

The reason as to why the drug would cause kidney damage is still unclear. In September 2004 Merck & Co Inc. withdrew Vioxx from the market after a three-year study revealed that it doubled the risk of heart attack and strokes in patients taking it for at least 18 months.

Another report from the University of Newcastle, New South Wales, Australia, following a review of 23 studies confirms the findings of an increased risk of heart problems with Vioxx that could be found "during the first 30 days of treatment in contrast to the the original suggestion that the vascular risk was only seen after 18 months."

Merck, however, facing more than 11,500 product liability lawsuits from people with claims of problems from Vioxx, has said that it still believes the data confirm the increased heart risk begins only after the medicine had been taken for 18 months.

The Australian analysis also found that celecoxib commonly sold as Celebrex and marketed by Pfizer Inc. was not associated with heart problems at a dose no greater than 200 milligrams a day.

Its review has also raised serious questions about the safety of diclofenac, an older (analgesic) drug marketed more in Europe than the United States.

The report added, "In conclusion ... diclofenac seems to share this risk and, unlike celecoxib, it appears to be harmful at commonly used doses. We believe there are grounds for reviewing its regulatory status."

The research details hav
'"/>




Page: 1 2

Related medicine news :

1. Painkillers Do Not Shorten Dying Patients Lives
2. Painkillers may protect against Alzheimers disease
3. Painkillers may raise miscarriage risk
4. Painkillers Increase Risk of Miscarriage
5. In The Habit Of Taking Painkillers For Your Chronic Headache? Time To Switch Over
6. Aspirin Might Counter Side Effects of Cox-2 Painkillers
7. Painkillers Lead To Liver Failure
8. Study Advocates Use Of Oral Painkillers After Cesarean Section
9. Overdose of Opioid Painkillers Can Kill Pain and The Patient
10. UK Recommendations On Painkillers Flaunted
11. Painkillers—New and Old—Increase the Risk for Heart Attak

Post Your Comments:
(Date:11/30/2009)...re/ -- Harrington Physician Services (HPS) is plea...ysicians Martin Devine, Leah Doret, Elizabeth Full..., These four esteemed and popular Charlton-base...soon join the Harrington family in the new Harring... under construction at 10 North Main Street, at th...
(Date:11/30/2009)...registration of a visual stimulus by the unconscio...; between the time we see an apple and the time we...r eyes, but by how long? And how does this affect ...stimates say the time delay lasts only 100 millise... Tel Aviv University psychologists says that the a...
(Date:11/30/2009)...y designed program, study finds , , MOND...ve early intervention program for toddlers with au...s language and social skills, a new study shows. ,...able to learn and make remarkable progress," said ...hed online Nov. 30 in Pediatrics , and chief sci...
(Date:11/30/2009)...0 Sunlamps and tanning ...but the ultraviolet (UV) radiation from these devi...p://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ...ves them a ,healthy, glow, any tan is a sign of sk...nd Drug Administration (FDA) scientist and interna...
(Date:11/30/2009)...Physicians at Beth Israel Deaconess Medical Center...onstrating the potential for automated analysis of...alyzer System® to assist in rapidly ruling ou...epartment (ED ) patients with chest pain. The abil...cCTA has potential to significantly reduce unneces...
Breaking Medicine News(10 mins):Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 3Health News:Now you see it, now you know you see it 2Health News:Working Intensely Early on May Help Autistic Kids 2Health News:Working Intensely Early on May Help Autistic Kids 3Health News:Working Intensely Early on May Help Autistic Kids 4Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3
... Texas, Nov. 6 The following was released today,b...eport from the U.S. Department of Veterans Affairs...1105-171) substantiated waste,mismanagement and in...ion to these serious disclosures constitutes viola...
... Net Sales increase 73% over Third Quarter 2007, ...Inc. (Nasdaq: ONXX ) today reported its financial...mber 30, 2008. Onyx reported net,income of $12.2 m...d in 2007. Excluding employee stock-based compensa...
...LOS, Calif., Nov. 6 Nektar,Therapeutics (Nasdaq: ...%, or,$100.0 million, of its outstanding convertib...for a total purchase price of $47.8 million. The,c...complete," said Nektar,President and CEO Howard W....
...errals should start with emergency room doctors, s...News) -- For children and teens who suffer violenc...oring on how to safely avoid conflict and diffuse ...ding gunshot, knife and fist-fight wounds -- at em...
... PfP Launches Ad Campaign Calli... , Washington, DC (PRWEB)...for Prevention said today that President-elect Oba...rdingly, the organization launched an ad campaign ...
...nce Call Scheduled for Today - Thursday, November ...tern Time, MOUNTAIN VIEW, Calif., Nov. 6 Alexza,...day financial results for,the quarter and nine mon...nded September 30, 2008, as reported in accordance...
Other Medicine News:Health News:War Veterans With Traumatic Brain Injury Pay the Price of Waste at the VA, Says Dr. Robert Van Boven 2Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 2Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 3Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 4Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 5Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 6Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 7Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 8Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 9Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 10Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 2Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 3Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 4Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 5Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 6Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 7Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 8Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 9Health News:Counseling Can Combat Youth Violence 2Health News:Obama's Call for "Change We Can Believe In" Makes Prevention a Priority in Health Reform 2Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 2Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 3Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 4Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 5Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 6Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 7Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 8Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 9Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 10
(Date:11/30/2009)... N.J., Nov. 30 MedQu...echnology-enabled clinical documentation services,...ological Society of North America (RSNA) conferenc... the product leverages SpeechQ(TM), the company,s ...on used by thousands of radiologists. MedQuist ha...
(Date:11/30/2009)...alif., Nov. 30 StemCyte, Inc. conc...greement with Academia Sinica, the National Labora...d Intellectual Property (IP) related to the treatm...d and IP was pioneered by a team led by Professor ... Professor Lin is currently the exclusive collabor...
(Date:11/30/2009)...YORK, Nov. 30 Reportlinker.com ann...ble in its catalogue: ,, Diabetes Diagnostics ...eportlinker.com/p0164347/Diabetes-Diagnostics---A-...agnosis market is driven by a steady increase in t...in the developed and developing parts of the world...
Breaking Medicine Technology:MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 4Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 5Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 6Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 7Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 8Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 9Top Five International Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 61111 1Top Five International Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 61111 2realbuzz com Top Tips to Cut the Calories This Christmas Party Season 61108 1realbuzz com Top Tips to Cut the Calories This Christmas Party Season 61108 2Worksite wellness programs may reduce employee absenteeism 61107 1Worksite wellness programs may reduce employee absenteeism 61107 2
... ROCK, Ark., Oct. 8 A research study,at the Unive...esigned to,establish one of the largest and most r...dy of breast cancer occurrence. Spit for the Cure...ousands of women and is being conducted with the s...or the Cure. The saliva samples will be used to,cr...
...A, Oct. 8 Alimera Sciences Inc., a privately held...mited (Nasdaq: PSDV; ASX:,PSD; Xetra: PSI), announ...(TM) (Fluocinolone Acetonide in Diabetic Macular E... Diabetic Macular Edema. FAME is a,double masked, ...ver 900,patients in the U.S., Canada, Europe and I...
Other Medicine Technology:Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research 2Enrollment Complete in Pivotal Phase 3 Trial of Medidur(TM) FA for Diabetic Macular Edema 2Enrollment Complete in Pivotal Phase 3 Trial of Medidur(TM) FA for Diabetic Macular Edema 3Enrollment Complete in Pivotal Phase 3 Trial of Medidur(TM) FA for Diabetic Macular Edema 4
Sealing Mat for 384-well PCR plate
MicroAmp 24-Well Full Plate Covers
Eppendorf Sealing Mat 96
AlumaSeal Aluminum sealing film for multiwell plates
Medicine Products: